Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma

Beat Foerster(Kantonsspital Winterthur), Andrea Necchi(Vita-Salute San Raffaele University), Ahmad Shabsigh(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Firas G. Petros(The University of Texas MD Anderson Cancer Center), Mounsif Azizi(Moffitt Cancer Center), Shoji Kimura(Jikei University School of Medicine), Wassim Kassouf(McGill University), Timothy N. Clinton, Phillip M. Pierorazio(University of Pennsylvania Health System), Nirmish Singla(Johns Hopkins University), Michiel S. van der Heijden(Zorginstituut Nederland), Alberto Briganti(University College London Hospitals NHS Foundation Trust), Takehiro Iwata(Okayama University), Philippe E. Spiess(Moffitt Cancer Center), Tim Muilwijk(KU Leuven), Tatevik Broutian(Columbus Oncology and Hematology Associates), D.G. Schweitzer(The Netherlands Cancer Institute), Yasutomo Nasu(Okayama University), Ross Liao(Johns Hopkins University), Leonardo L. Monteiro, Harun Fajković(University of Applied Sciences St Pölten), Trinity J. Bivalacqua(University of Pennsylvania), Kees Hendricksen(The Netherlands Cancer Institute), Shahrokh F. Shariat(Universitätszahnklinik Wien), Marco Bandini(IRCCS Ospedale San Raffaele), Laura‐Maria Krabbe, Marco Moschini(Vita-Salute San Raffaele University), Petr Glybochko(Sechenov University), Surena F. Matin(The University of Texas MD Anderson Cancer Center), Vitaly Margulis(Southwestern Medical Center), Mohit Gupta(Johns Hopkins University), Ja Hyun Ku(Seoul National University Hospital), Shin Egawa, Mohammad Abufaraj(University of Jordan), Hubert John, Steven Joniau
The Journal of Urology
January 3, 2020
Cited by 44


Related Papers